Epithalon vs Lanreotide
Overview
Epithalon is primarily a sleep & recovery peptide, while Lanreotide is used for hormonal.
This page compares Epithalon and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Epithalon | Lanreotide | |
|---|---|---|
| Category | Sleep & Recovery | Hormonal |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 5-10 mg | 60-120 mg |
| Frequency | cycle protocol | every 4 weeks |
| Reported benefits | Improved sleep quality, circadian rhythm regulation, anti-aging | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Minimal side effects during cycles | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. Epithalon is categorised under Sleep & Recovery, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Epithalon: not FDA-approved; compounding permitted with a prescription as of April 2026. Lanreotide: FDA-approved.
Dosing. Epithalon is typically dosed at 5-10 mg (cycle protocol). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking Epithalon and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Epithalon and Lanreotide?
- Epithalon is primarily a sleep & recovery peptide, while Lanreotide is used for hormonal. Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Lanreotide is FDA-approved for one or more indications.
- What is Epithalon used for?
- Circadian rhythm regulator.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take Epithalon and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking Epithalon and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Epithalon or Lanreotide FDA-approved?
- Epithalon is not FDA-approved; compounding permitted with a prescription (as of April 2026). Lanreotide is FDA-approved for one or more indications.
Read the full articles
- Epithalon — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references